Journals
Books
Articles by keyword PD-1
Key immune checkpoints and their inhibitors in the therapy of bone tumors. Part 1. Signaling system of programmed cell death protein 1 - PD-1/PD-L

A.A. Alferov¹, M.M. Efimova², Yu.B. Kuzmin³, I.N. Kuznetsov4, E.S. Gershtein5, N.E. Kushlinskii6

1–3, 5, 6 N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation  (Moscow, Russia)

4 A.I. Evdokimov Moscow University of Medicine and Dentistry of the Ministry of Health of the Russian Federation (Moscow, Russia)

Clinical implication of the programmed cell death-1 protein PD-1 and its ligand PD-L1 in ovarian cancer (review)

E.S. Gershtein – Dr. Sc. (Biol.), Professor, Leading Research Scientist, Clinical Biochemistry Laboratory, 

N.N. Blokhin National Medical Research Center of Oncology (Moscow)

D.N. Kushlinsky – Ph.D. (Med.), Senior Research Scientist, Department of Radiation and Combined Treatment of Gynecological Diseases, Medical Radiological Scientific Center n.a. A.F. Tsyba – Branch of the Federal State

Budgetary Institution «National Medical Center of Radiology» of the Ministry of Health  of Russian Federation (Moscow)

I.V. Tereshkina – Ph.D. (Med.), Clinical Biochemistry Laboratory, N.N. Blokhin National Medical Research  Center of Oncology (Moscow)

D.O. Utkin – Surgeon, Department of Oncogynecology, Moscow City Oncological Hospital № 62» (Moscow)

N.E. Kushlinskii – Dr.Sc. (Med.), Professor, Academician of RAS, Heard of Clinical Biochemistry Laboratory, N.N. Blokhin National Medical Research Center of Oncology (Moscow)

Clinical significance of immune checkpoint PD-1/PD-L1 colorectal cancer

O.V. Kovaleva1, V.V. Maslennikov2, N.Yu. Sokolov3, M.M. Kontorshchikov4,  A.S. Mochalova5, N.E. Kushlinskii6

1,3,5,6 N.N. Blokhin National Medical Research Center of Oncology (Moscow, Russia)

2 A.I. Evdokimov Moscow University of Medicine and Dentistry  of Ministry of Health of the Russian Federation (Moscow, Russia)

4 Volga Research Medical University (Nizhny Novgorod, Russia)

Immune checkpoints and their soluble forms in bone tumors

N.E. Kushlinskii1, A.A. Alferov2, Yu.B. Kuzmin3, P.L. Prishchep4, I.S. Chernomaz5, N.Yu. Sokolov6, I.N. Kuznetsov7, I.S. Stilidi8

1,2,4-6,8 N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia (Moscow, Russia)

3,7 Russian University of Medicine of the Ministry of Health of Russia (Moscow, Russia)

1 kne3108@gmail.com, 2 aleksandr.alferov@yahoo.com, 3 yriikuzmin@yandex.com, 4 Paulig92@mail.ru, 5 marvel2602@mail.ru, 6 strivp@mail.ru, 7 npkredo@yandex.ru, 8 ronc@list.ru